B.Riley sets Anika stock Buy rating, $21 target
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Anika Therapeutics Inc (ANIK)
"Anika Therapeutics Inc stock price live, this page displays NASDAQ ANIK stock exchange data. View the ANIK premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Anika Therapeutics Inc real time stock price chart below.
What Is the Anika Therapeutics Inc Stock Price Today?
The Anika Therapeutics Inc stock price today is 14.03.
What Is the Stock Symbol for Anika Therapeutics Inc?
The stock symbol for Anika Therapeutics Inc is ""ANIK.""
What Stock Exchange Does Anika Therapeutics Inc Trade On?
Anika Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Anika Therapeutics Inc a Good Stock to Buy?
Determining whether Anika Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANIK quote. (ISIN: US0352551081)"
What Is the Anika Therapeutics Inc Stock Price Today?
The Anika Therapeutics Inc stock price today is 14.03.
What Is the Stock Symbol for Anika Therapeutics Inc?
The stock symbol for Anika Therapeutics Inc is ""ANIK.""
What Stock Exchange Does Anika Therapeutics Inc Trade On?
Anika Therapeutics Inc is listed and trades on the NASDAQ stock exchange.
Is Anika Therapeutics Inc a Good Stock to Buy?
Determining whether Anika Therapeutics Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ANIK quote. (ISIN: US0352551081)"
NASDAQ
Currency in USD
14.03
+0.01(+0.07%)
Closed·
Pre Market
14.35+0.32(+2.28%)
·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.60
14.50
52 wk Range
12.83
29.12
ANIK Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 15 days
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.6014.50
52 wk Range
12.8329.12
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ANIK Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
23.00
Upside
+63.93%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Holds more cash than debt on its balance sheet
- Anika Therapeutics stock hits 52-week low at $14.9
- Investing.com
- Anika Therapeutics stock hits 52-week low at $15.34
- Investing.com
- B.Riley sets Anika stock Buy rating, $21 target
- Investing.com
- Anika Therapeutics stock hits 52-week low at $13.7
- Investing.com
Anika Therapeutics Inc Company Profile
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, sports medicine, and arthrosurface joint solutions in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain management products include Monovisc and Orthovisc, an injectable HA-based viscosupplement for the pain relief from osteoarthritis conditions; and Cingal, a single-injection OA pain management product to provide short-and long-term pain relief. The company’s joint preservation and restoration product family comprises orthopedic regenerative solutions, including Hyalofast and Tactoset; sports medicine solutions to repair and reconstruct damaged ligaments and tendons; and preserving joint solutions, including partial joint replacement, joint resurfacing, and invasive and bone sparing implants to treat upper and lower extremity orthopedic conditions. In addition, the company offers non-orthopedic products comprising HA-based products for Hyvisc, a molecular weight injectable HA veterinary product; Hyalobarrier, an anti-adhesion barrier for use after abdominal-pelvic surgeries; and Hyalomatrix for the treatment of burns and ulcers, as well as products used for the treatment of ears, nose and throat disorders, and ophthalmic. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Anika Therapeutics Inc Earnings Call Summary for Q4/2024
- Anika Therapeutics Q4 2024 EPS beat expectations at -$0.03 vs -$0.23 forecast; revenue reached $30.6M, exceeding $29M estimate
- Despite earnings beat, stock fell 1.52% in aftermarket trading; company appears undervalued based on InvestingPro's Fair Value analysis
- Commercial channel revenue grew 25% in Q4, while OEM channel declined 8%; full-year revenue slightly decreased 1% to $119.9M
- 2025 outlook: commercial revenue growth 12-18%, OEM revenue decline 12-18%; adjusted EBITDA margin target 8-10%
- Company completed $15M stock repurchase plan early; focuses on expanding international OA pain management products and Integrity technology
Last Updated: 2025/03/12, 23:54
Read Full TranscriptCompare ANIK to Peers and Sector
Metrics to compare | ANIK | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipANIKPeersSector | |
|---|---|---|---|---|
P/E Ratio | −22.5x | −0.7x | −0.5x | |
PEG Ratio | −0.69 | 0.04 | 0.00 | |
Price/Book | 1.3x | 3.7x | 2.6x | |
Price / LTM Sales | 1.7x | 15.1x | 2.9x | |
Upside (Analyst Target) | 51.6% | 42.3% | 60.8% | |
Fair Value Upside | Unlock | 8.7% | 10.8% | Unlock |
Analyst Ratings
3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 23.00
(+63.93% Upside)
Earnings
Latest Release
Mar 12, 2025
EPS / Forecast
-0.03 / -0.23
Revenue / Forecast
30.60M / 29.00M
FAQ
What Is the Anika (ANIK) Stock Price Today?
The Anika stock price today is 14.03
What Stock Exchange Does Anika Trade On?
Anika is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for Anika?
The stock symbol for Anika is "ANIK."
What Is the Anika Market Cap?
As of today, Anika market cap is 198.89M.
What is Anika Earnings Per Share?
The Anika EPS is -0.60.
What Is the Next Anika Earnings Date?
Anika will release its next earnings report on 06 May 2025.
From a Technical Analysis Perspective, Is ANIK a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.